Vitamin D3 Supplementation Effects on Spermatogram and Oxidative Stress Biomarkers in Asthenozoospermia Infertile Men: a Randomized, Triple-Blind, Placebo-Controlled Clinical Trial

被引:0
|
作者
Leila Maghsoumi-Norouzabad
Ahmad Zare Javid
Anahita Mansoori
Mohammadreza Dadfar
Amirarsalan Serajian
机构
[1] Ahvaz Jundishapur University of Medical Sciences,Department of Nutrition, School of Allied Medical Sciences
[2] Ahvaz Jundishapur University of Medical Sciences,Nutrition and Metabolic Diseases Research Center
[3] Imam Khomeini Hospital,Department of Urology, School of Medicine
[4] Ahvaz Jundishapur University of Medical Sciences,undefined
[5] Health Education Group,undefined
[6] Jahad Daneshgahi,undefined
来源
Reproductive Sciences | 2022年 / 29卷
关键词
Vitamin D3; Oxidative stress; Asthenozoospermia; Sperm quality;
D O I
暂无
中图分类号
学科分类号
摘要
The objective is to evaluate the effects of vitamin D3 (VD3) on sperm parameters and seminal and serum oxidative stress (OS) biomarkers in asthenozoospermia infertile men. This randomized, triple-masking, placebo-controlled clinical trial conducted on 86 asthenozoospermia infertile men with serum 25 hydroxy vitamin D3 (25-OH-D3) < 30 ng/ml in the infertility clinic of Ahvaz Jahad Daneshgahi, Iran. Patients were randomly allocated to groups A and B, who received daily 4000 IU vitamin D3 (VD3) and matching placebo respectively for 3 months. Demographic data, dietary intake, physical activity, sun exposure, anthropometric indices, serum and seminal levels of MDA (Malondialdehyde), 8-hydroxy-2- Dioxy Guanosine (8-OHDG), total antioxidant capacity (TAC) and calcium, sperm DNA fragmentation index (DFI), serum 25-OH-D3, parathyroid hormone (PTH), phosphorus, and sperm parameters were assessed. VD3 supplementation had no significant effects on body weight, body mass index (BMI), waist circumference (WC), body fat (BF), 8-OHDG, DFI, semen volume, sperm count, and normal sperm morphology, but increased post-intervention mean and mean change of serum 25-OH-D3 (P < 0.001, P < 0.001), PTH (P < 0.001, P < 0.001) and phosphorus (P = 0.009, P = 0.049) and seminal calcium (P = 0.035, P = 0.038) and serum calcium (P = 0.008, P = 0.009), seminal TAC (P < 0.001, P < 0.001), and serum TAC (P = 0.007, P = 005), total sperm motility (P < 0.001, P < 0.001) and progressive sperm motility (P < 0.001, P < 0.001) and decreased seminal MDA (P = 0.017, P = 0.004) and serum MDA (P = 006, P = 0.005) significantly compared to the baseline and placebo group respectively. VD3 supplementation may modulate OS and affect sperm motility in men with asthenozoospermia and serum 25-OH-D3 < 30 ng/ml. Iran Clinical Trials Registry, ID: IRCT20151128025274N4, registered on 28 March 2018, URL of trial registry record: https://www.irct.ir/trial/29983
引用
收藏
页码:823 / 835
页数:12
相关论文
共 50 条
  • [41] Effect of vitamin D3 supplementation on insulin resistance and β-cell function in prediabetes: a double-blind, randomized, placebo-controlled trial
    Wallace, Helen J.
    Holmes, Lauren
    Ennis, Cieran N.
    Cardwell, Christopher R.
    Woodside, Jayne V.
    Young, Ian S.
    Bell, Patrick M.
    Hunter, Steven J.
    McKinley, Michelle C.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2019, 110 (05): : 1138 - 1147
  • [42] Effect of Oral Vitamin D3 Supplementation in Exclusively Breastfed Newborns: Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
    Lin, Chao-Hsu
    Lin, Chien-Yu
    Sung, Yi-Hsiang
    Li, Sung-Tse
    Cheng, Bi-Wen
    Weng, Shun-Long
    Chang, Shing-Jyh
    Lee, Hung-Chang
    Lee, Yann-Jinn
    Ting, Wei-Hsin
    Chang, Hung-Yang
    Wu, Yi-Lei
    Lin, Chih-Sheng
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 (04) : 786 - 793
  • [43] Melatonin supplementation for the treatment of infantile spasms: protocol for a randomised placebo-controlled triple-blind trial
    Sun, Yulin
    Feng, Weiwei
    Chen, Jian
    Liu, Miao
    Shi, Xiuyu
    Wang, Jing
    Zou, Liping
    Xu, Tao
    Yang, Guang
    BMJ OPEN, 2022, 12 (07):
  • [44] Vitamin D supplementation for primary dysmenorrhea: a double-blind, randomized, placebo-controlled trial
    Rahnemaei, Fatemeh Alsadat
    Gholamrezaei, Ali
    Afrakhteh, Maryam
    Zayeri, Farid
    Vafa, Mohammad Reza
    Rashidi, Arian
    Ozgoli, Giti
    OBSTETRICS & GYNECOLOGY SCIENCE, 2021, 64 (04) : 353 - 363
  • [45] Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease
    Suzuki, Masahiko
    Yoshioka, Masayuki
    Hashimoto, Masaya
    Murakami, Maiko
    Noya, Miki
    Takahashi, Daisuke
    Urashima, Mitsuyoshi
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2013, 97 (05): : 1004 - 1013
  • [46] Vitamin D supplementation in subjects with hypovitaminosis D: a randomized double-blind, placebo-controlled trial
    Nugroho, Heri
    Tjokorda, G. D. P.
    Suhartono, Tony
    Darmono
    BALI MEDICAL JOURNAL, 2021, 10 (01) : 405 - 411
  • [47] Clinical trial: vitamin D3 treatment in Crohn's disease - a randomized double-blind placebo-controlled study
    Jorgensen, S. P.
    Agnholt, J.
    Glerup, H.
    Lyhne, S.
    Villadsen, G. E.
    Hvas, C. L.
    Bartels, L. E.
    Kelsen, J.
    Christensen, L. A.
    Dahlerup, J. F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (03) : 377 - 383
  • [48] The Effect of Vitamin D Supplementation on Epigenetic Aging: A Randomized Placebo-Controlled Clinical Trial
    Chen, Li
    Dong, Yanbin
    Bhagatwala, Jigar
    Raed, Anas
    Huang, Ying
    Zhu, Haidong
    CIRCULATION, 2018, 137
  • [49] Vitamin D supplementation to persistent carriers of MRSA—a randomized and placebo-controlled clinical trial
    Linda Björkhem-Bergman
    Catharina Missailidis
    John Karlsson-Valik
    Ann Tammelin
    Lena Ekström
    Matteo Bottai
    Ulf Hammar
    Gudrun Lindh
    Peter Bergman
    European Journal of Clinical Microbiology & Infectious Diseases, 2018, 37 : 1735 - 1744